Brief: Eterna Therapeutics Says Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq

Ernexa Therapeutics

19/01/2024 22:01

Jan 19 (Reuters) - Eterna Therapeutics Inc  ERNA.O :
    * ETERNA THERAPEUTICS INC:  ON JANUARY 17, 2024 CO RECEIVED
NOTICE
OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ

Further company coverage:  ERNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))